Is the FDA Poised to Crack Down on E-Cigs?

Before you go, we thought you'd like these...
Before you go close icon

Word is starting to leak out that the Food and Drug Administration is about to exert its power over the increasingly popular electronic cigarette market.

Demand for e-cigs continues to gain steam; Lorillard controls half the market and saw 25% growth from its Blu brand. However, watchdog groups are up in arms over the industry's loose regulations, highlighting what they see as youth-friendly flavors like tuti-frutti and skyrocketing rates of poisonings from inhaling too much nicotine vapor. 

On this edition of Market Checkup, Motley Fool health-care analysts David Williamson and Michael Douglass discuss the FDA's coming regulatory power move, how this could affect tobacco stocks, and what they see as the long-term sales potential of e-cigs.

Take advantage of this little-known tax "loophole"
Recent tax increases have affected nearly every American taxpayer. But with the right planning, you can take steps to take control of your taxes and potentially even lower your tax bill. In our brand-new special report "The IRS Is Daring You to Make This Investment Now!," you'll learn about the simple strategy to take advantage of a little-known IRS rule. Don't miss out on advice that could help you cut taxes for decades to come. Click here to learn more.

The article Is the FDA Poised to Crack Down on E-Cigs? originally appeared on

David Williamson, Michael Douglass, and The Motley Fool have no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2014 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Read Full Story

Sign up for Finance Report by AOL and get everything from business news to personal finance tips delivered directly to your inbox daily!

Subscribe to our other newsletters

Emails may offer personalized content or ads. Learn more. You may unsubscribe any time.

People are Reading